P. M. Ridker Et Al. , "Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients," NEW ENGLAND JOURNAL OF MEDICINE , vol.376, no.16, pp.1527-1539, 2017
Ridker, P. M. Et Al. 2017. Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients. NEW ENGLAND JOURNAL OF MEDICINE , vol.376, no.16 , 1527-1539.
Ridker, P. M., Revkin, J., Amarenco, P., Brunell, R., Curto, M., Civeira, F., ... Flather, M.(2017). Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients. NEW ENGLAND JOURNAL OF MEDICINE , vol.376, no.16, 1527-1539.
Ridker, P. Et Al. "Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients," NEW ENGLAND JOURNAL OF MEDICINE , vol.376, no.16, 1527-1539, 2017
Ridker, P. M. Et Al. "Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients." NEW ENGLAND JOURNAL OF MEDICINE , vol.376, no.16, pp.1527-1539, 2017
Ridker, P. M. Et Al. (2017) . "Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients." NEW ENGLAND JOURNAL OF MEDICINE , vol.376, no.16, pp.1527-1539.
@article{article, author={P. M. Ridker Et Al. }, title={Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients}, journal={NEW ENGLAND JOURNAL OF MEDICINE}, year=2017, pages={1527-1539} }